Is it ordinary forgetfulness, or something more?
Everyone misplaces keys. Here is how doctors tell the difference between normal age-related changes and memory problems that deserve a closer look.
A.It is the question I hear most, from patients and from the families sitting beside them. This site answers it, and the questions that follow, in plain language and with the evidence shown.
Pick the question closest to yours. Each one leads to a full answer.
How to tell everyday slips from changes that need a closer look.
Read the answerMy doctor said “mild cognitive impairment.” What now?What MCI means, what causes it, and what you can do next.
Read the answerIs one of the new Alzheimer's drugs right for my mother?Lecanemab and donanemab: who they're for, risks and honest trade-offs.
Read the answerI'm caring for my husband and I'm running on empty.Support for care partners, and how to bring them into visits.
See support for familiesCan I lower my own risk of dementia?The 14 modifiable risk factors, and what recent trials found.
Read the answerHow do I join a research study?How trials work, your rights, and where to search.
Learn about researchMemory changes deserve a real evaluation: not a shrug, and not a panic.
Dr. Neelum Aggarwal is a board-certified cognitive neurologist, clinical trialist and Professor in the Department of Neurological Sciences at Rush University Medical Center in Chicago.
She is senior examining neurologist for the Rush Alzheimer's Disease Center's Clinical Core, where she diagnoses and cares for people with memory changes, mild cognitive impairment, vascular cognitive impairment and Alzheimer's disease. She is also research director of the Rush Heart Center for Women and works with its Cardiology Cognitive Clinic, which brings heart and brain care together.
Her research looks at why some people are at higher risk of cognitive decline: heart and blood-vessel health, social circumstances, and differences between women and men. She has helped lead national Alzheimer's prevention and treatment trials at Rush.
Read Dr. Aggarwal's backgroundThe numbers behind the questions. Each comes from a published source, listed below.
Americans aged 65 and older living with Alzheimer's disease in 2026
Alzheimer's Association, 2026 Facts and Figuresof Americans with Alzheimer's are women — almost two in every three
Alzheimer's Association, 2026 Facts and Figuresestimated lifetime risk of Alzheimer's for a woman at age 45 (1 in 10 for a man)
Alzheimer's Association, 2026 Facts and FiguresNearly that many Americans give unpaid care to someone living with dementia
Alzheimer's Association, 2026 Facts and Figuresof dementia cases worldwide potentially linked to 14 modifiable risk factors
Lancet Commission, 2024Sources: Alzheimer's Association, 2026 Alzheimer's Disease Facts and Figures; Livingston et al., Lancet 2024. The 45% figure is a worldwide population estimate, not an individual's risk.
Six beliefs that keep families from getting help, and what the evidence says instead.
Some slowing is normal with age. Memory loss that disrupts daily life is not, and it deserves an evaluation.
Family history raises risk, but it is not destiny. Genes that directly cause Alzheimer's are rare, and many people with an affected parent never develop it.
Some causes of memory trouble are treatable. An early, accurate diagnosis also opens doors to treatment choices, planning and research.
Many people with MCI stay stable for years, and some return to normal thinking. The cause makes a big difference.
Supplements are not reviewed by the FDA for effectiveness. The strongest evidence points to heart health, hearing care, activity and social connection.
Many studies seek healthy volunteers or people with early memory concerns. Taking part is voluntary, and you can leave at any time.
A simplified guide. Only a full evaluation can tell which applies to a particular person.
| Typical aging | Mild cognitive impairment | Dementia | |
|---|---|---|---|
| Memory | Occasionally forgets a name or appointment, remembers later | Forgets more than expected for age; noticeable on testing | Memory loss that disrupts daily life; new information is quickly lost |
| Daily life | Fully independent | Mostly independent; complex tasks may take more effort | Needs help with tasks such as bills, medicines, cooking or driving |
| Who notices | Usually the person themselves | The person and often close family | Family and friends; the person may not be aware |
| Over time | Stable | May stay stable, improve, or progress | Usually progresses; the pace varies by cause |
| Next step | Healthy habits; mention concerns at check-ups | Evaluation to find the cause; follow-up every 6–12 months | Diagnosis, treatment options, safety and support planning |
Based on information from the Alzheimer's Association on warning signs and mild cognitive impairment.
Because every test and treatment patients rely on today was proven, or disproven, by volunteers in research.
Dr. Aggarwal has served as a site principal investigator and steering committee member for NIH-funded Alzheimer's trials. She has also worked to make it easier for women and people from diverse communities to take part.
How research participation worksPurpose, visits, risks, and whether a placebo is used.
With family, your own doctor and the study team.
Only if you choose to. You can leave at any time.
Regular visits and monitoring for your safety.
Recent answers from the column.
Everyone misplaces keys. Here is how doctors tell the difference between normal age-related changes and memory problems that deserve a closer look.
MCI sits between normal aging and dementia. It is common, it doesn't always progress, and knowing the cause can open real options.
Two anti-amyloid medicines are FDA-approved for early Alzheimer's disease. Here is who they are for, how they are given, the risks, and why experts still debate the size of the benefit.
Almost two-thirds of Americans with Alzheimer's are women. Living longer is part of the story, but researchers are finding it is not the whole story.
Content is written for and approved by Dr. Aggarwal, a cognitive neurologist.
Medical statements cite guidelines and studies, linked on every page.
Each medical page shows when it was last reviewed, and is re-checked as treatments change.
No advertising, no paid placements, no products for sale.
General education only. Pages say when to see a doctor or call 911.
Where experts disagree, as they do about the new Alzheimer's drugs, both sides are shown.
Email [email protected] and the office will reply with how to book a visit with Dr. Aggarwal at Rush University Medical Center.